{
  "ptid_time": "127_S_4240_2011-12-14",
  "img_path": "/data/qiuhui/data/adni/images/127_S_4240/2011-12-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,852 mm³, 4.3% below the reference mean. With a Z-score of -0.10 (45.9th percentile), this represents normal volume ; hippocampal volume measures 5,341 mm³, 29.3% below the reference mean. With a Z-score of -2.86 (0.2th percentile), this represents significant atrophy; whole brain volume measures 1,002,720 mm³, 7.1% below the reference mean. With a Z-score of -0.92 (17.8th percentile), this represents normal volume ; entorhinal cortex volume measures 3,058 mm³, 25.4% below the reference mean. With a Z-score of -1.72 (4.2th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,680 mm³, 22.1% below the reference mean. With a Z-score of -1.88 (3.0th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 19,472 mm³, 8.7% below the reference mean. With a Z-score of -0.79 (21.6th percentile), this represents normal volume . ",
  "text_data": "Age is 70.8 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Respiratory; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. MoCA: 23.0. Logical Memory: 0.0. Laboratory findings: Vitamin B12: 981.00 (significant elevated); Neutrophils: 77.00 (significant elevated); Lymphocytes: 13.30 (significant reduced); Lymphocytes: 0.74 (significant reduced). APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.51 SUVR (profound elevated); Amyloid beta: 337.50 pg/mL (moderate reduced); Total tau: 270.90 pg/mL (normal ); Phosphorylated tau: 27.73 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant hippocampal atrophy (Z-score -2.86) and moderate atrophy in the entorhinal cortex and fusiform gyrus, which are key regions affected in Alzheimer’s disease. Despite a normal MMSE (28), the MoCA (23) suggests mild cognitive impairment, supported by elevated AV45 (amyloid PET) and APOE4 homozygosity.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Rationale: Structural atrophy in AD-vulnerable regions, amyloid positivity, and borderline cognitive scores strongly suggest MCI with underlying AD pathology.)*",
  "timestamp": "2025-07-26T13:17:12.068667"
}